A carregar...

The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility

INTRODUCTION: Symptoms of severe intestinal dysmotility decrease patients’ quality of life and may prevent them from sustaining adequate oral intake. Dronabinol is a synthetic cannabinoid that is labeled for use in AIDS-related anorexia and chemotherapy-associated nausea and vomiting that has additi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Surg Case Rep
Main Authors: Taylor, Grace H., Schwaitzberg, Steven D.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4446691/
https://ncbi.nlm.nih.gov/pubmed/25974259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijscr.2015.04.036
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!